天士力

600535 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

21.1B ($3.1B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

8.2B

Net Income

1.1B

Gross Margin

N/A

Op. Margin

16.5%

Net Margin

12.9%

ROE

8.5%

ROA

6.9%

D/E

0.22

Dividend Yield

N/A

EPS

0.74

Current Ratio

3.57

Price History

Company Info

Industry	C27医药制造业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2025

Business Overview

Tasly Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells medicines and related pharmaceuticals in China and internationally. The company provides prescription drugs covering various therapeutic areas, including cardiovascular and cerebrovascular, hepato-biliary-pancreatic, respiratory system, diabetes, tumor immunity, gastrointestinal disease, gynecological, rheumatism, soothe the nerves, pruritus, and andrological areas, as well as over-the-counter drugs. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 天士力

Ticker	600535
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业